PAA 5.00% 19.0¢ pharmaust limited

Ann: PAA completes Phase 1 and files for Orphan Drug Designation, page-397

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,453 Posts.
    lightbulb Created with Sketch. 1179
    If my understanding is correct once approval is given by the FDA that drug could be prescribed by a GP for another ailment if she/he thinks it would help.
    Quiltman has pointed out there is no treatment for FTD, if Monepantel is approved for MND there may well be a treatment worth trying for FTD especially as there are no side effects.
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
19.0¢
Change
-0.010(5.00%)
Mkt cap ! $92.46M
Open High Low Value Volume
19.5¢ 20.0¢ 19.0¢ $118.1K 605.7K

Buyers (Bids)

No. Vol. Price($)
6 271759 19.0¢
 

Sellers (Offers)

Price($) Vol. No.
20.0¢ 84950 5
View Market Depth
Last trade - 15.35pm 08/10/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.